In hematologic malignancies, a deregulation and constitutive expression or activation of proteins of the apolipoprotein B mRNA-editing enzyme catalytic polypeptide (APOBEC) family of deaminases, which are involved in oncogenesis, has been reported56–61. Here, APOB is linked to hematologic disorder.